169 related articles for article (PubMed ID: 23097387)
1. Might the beneficial effects of statin drugs be related to their action on iron metabolism?
Mascitelli L; Goldstein MR
QJM; 2012 Dec; 105(12):1225-9. PubMed ID: 23097387
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
3. Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction.
Ito MK; Talbert RL; Tsimikas S
Pharmacotherapy; 2006 Jul; 26(7 Pt 2):85S-97S; discussion 98S-101S; quiz 106S-108S. PubMed ID: 16803418
[TBL] [Abstract][Full Text] [Related]
4. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
Robinson JG
Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
[TBL] [Abstract][Full Text] [Related]
5. Statins and cardioprotection--more than just lipid lowering?
Ludman A; Venugopal V; Yellon DM; Hausenloy DJ
Pharmacol Ther; 2009 Apr; 122(1):30-43. PubMed ID: 19318042
[TBL] [Abstract][Full Text] [Related]
6. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
7. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
[TBL] [Abstract][Full Text] [Related]
8. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins.
Lahera V; Goicoechea M; de Vinuesa SG; Miana M; de las Heras N; Cachofeiro V; Luño J
Curr Med Chem; 2007; 14(2):243-8. PubMed ID: 17266583
[TBL] [Abstract][Full Text] [Related]
9. Statin pleiotropy: fact or fiction?
Futterman LG; Lemberg L
Am J Crit Care; 2004 May; 13(3):244-9. PubMed ID: 15149060
[TBL] [Abstract][Full Text] [Related]
10. [Anti-atherosclerotic and anti-inflammatory effects of statin on cardiovascular disease and their mechanisms].
Ishibashi T
Nihon Rinsho; 2011 Jan; 69(1):79-84. PubMed ID: 21226265
[TBL] [Abstract][Full Text] [Related]
11. Statins and stroke.
Endres M
J Cereb Blood Flow Metab; 2005 Sep; 25(9):1093-110. PubMed ID: 15815580
[TBL] [Abstract][Full Text] [Related]
12. Pleiotropic effects of HMG-CoA reductase inhibitors.
Bocan TM
Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
[TBL] [Abstract][Full Text] [Related]
13. Plaque regression and improved clinical outcomes following statin treatment in atherosclerosis.
Girotra S; Murarka S; Migrino RQ
Panminerva Med; 2012 Jun; 54(2):71-81. PubMed ID: 22525562
[TBL] [Abstract][Full Text] [Related]
14. Pleiotropic effects of statins and related pharmacological experimental approaches.
Alegret M; Silvestre JS
Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729
[TBL] [Abstract][Full Text] [Related]
15. Anti-atherosclerotic effects of statins: lessons from prevention trials.
Ganesh SK; Nass CM; Blumenthal RS
J Cardiovasc Risk; 2003 Jun; 10(3):155-9. PubMed ID: 12775947
[TBL] [Abstract][Full Text] [Related]
16. Exploring new indications for statins beyond atherosclerosis: Successes and setbacks.
Waters DD
J Cardiol; 2010 Mar; 55(2):155-62. PubMed ID: 20206067
[TBL] [Abstract][Full Text] [Related]
17. A proteomic approach for investigating the pleiotropic effects of statins in the atherosclerosis risk in communities (ARIC) study.
Bohn B; Lutsey PL; Tang W; Pankow JS; Norby FL; Yu B; Ballantyne CM; Whitsel EA; Matsushita K; Demmer RT
J Proteomics; 2023 Feb; 272():104788. PubMed ID: 36470581
[TBL] [Abstract][Full Text] [Related]
18. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
Marzilli M
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
[TBL] [Abstract][Full Text] [Related]
19. [Pleiotrophic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors)].
Igel M; Sudhop T; von Bergmann K
Arzneimittelforschung; 2003; 53(8):545-53. PubMed ID: 13677244
[TBL] [Abstract][Full Text] [Related]
20. The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases.
Almog Y; Novack V; Eisinger M; Porath A; Novack L; Gilutz H
Crit Care Med; 2007 Feb; 35(2):372-8. PubMed ID: 17205009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
